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Abstract
Purpose To present the extent and site of lesion of auditory dysfunction in a large cohort of individuals with type 2 Stickler 
Syndrome. Type 2 Stickler Syndrome results from a mutation in the gene coding for α-1 type XI pro-collagen, which has 
been identified in the human vitreous, cartilage and the cochlea of the mouse. The condition is characterised by classic ocular 
abnormalities, auditory dysfunction, osteoarthropathy and oro-facial dysplasia.
Methods This is a population study which used a combination of audiometric, tympanometric, and self-report measures 
on a series of 65 individuals (mean age 29.2 years, range 3–70, female 63.1%) with genetically confirmed type 2 Stickler 
Syndrome.
Results Hearing impairment was identified in at least one ear for 69% of individuals. Analysis against age-matched norma-
tive data showed that reduced hearing sensitivity was present across all test frequencies. Sensorineural hearing loss was 
most common (77% of ears), with conductive (3%), mixed (7%) and no hearing loss (13%), respectively. The proportion of 
hypermobile tympanic membranes (24%) was less than previously documented in type 1 Stickler Syndrome. When present, 
this appears to arise as a direct result of collagen abnormalities in the middle ear. Self-report measures of speech and spatial 
hearing in sound were comparable to a non-syndromic cohort with similar audiometric thresholds.
Conclusions Auditory impairment in type 2 Stickler Syndrome is predominantly associated with cochlear hearing loss of 
varying severities across affected individuals. The impact on hearing thresholds can be seen across the frequency range, 
suggesting a contribution of defective collagen throughout the cochlea. Self-report questionnaires showed that difficulties 
understanding speech, and spatial information in sound (such as that used for localisation), were worse than a young, normal-
hearing population but comparable to a non-syndromic cohort with similar audiometric thresholds. Therefore, it is likely 
that hearing loss in type 2 Stickler Syndrome arises in the auditory periphery, without significant central processing deficits.
Keywords Stickler Syndrome · Type 2 · Conductive · Sensorineural · Hearing loss · Retinal detachment · COL11A1 · 
COL2A1
Introduction
In 1965, Dr. Gunnar Stickler and colleagues described a 
dominant “hereditary arthro-ophthalmopathy” characterised 
by premature degenerative osteoarthropathy, and progressive 
myopia beginning in the first decade of life and frequently 
resulting in retinal detachment and blindness [1]. Originally 
considered a single gene disorder, at least nine genes are 
now known to cause Stickler Syndrome [2, 3], but the vast 
majority result from abnormalities in either Type II, Type IX 
or Type XI collagen. This cluster of conditions, best referred 
to as the Stickler Syndromes, is among the most frequently 
inherited connective tissue disorders, accounting for 1:7500 
births [4, 5]. Type 1 Stickler Syndrome, caused by muta-
tions in COL2A1 (the gene encoding the α-1 chain for Type 
II collagen) accounts for more than 80% of Stickler Syn-
drome patients [6]. Type 2 Stickler Syndrome results from 
a mutation in the gene coding for α-1 type XI pro-collagen, 
which has been identified in the human vitreous, cartilage 
and the cochlea of the mouse. The condition is characterised 
by classic ocular abnormalities, auditory dysfunction, osteo-
arthropathy and oro-facial dysplasia.
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Mild hearing loss, affecting the mid- to high frequen-
cies, was first associated with this condition by Stickler 
and Pugh in 1967 [7]. Auditory dysfunction in the Stick-
ler Syndromes may be conductive, sensorineural or mixed. 
Conductive hearing loss secondary to glue ear and serous 
otitis media is a well-recognised complication of cleft palate 
[8, 9], which itself is a feature of the Stickler Syndromes; 
ossicular abnormalities may also contribute to conductive 
loss [10]. Sensorineural hearing loss can also occur but its 
pathogenesis is less certain [11].
Hearing loss is thought to be more common and more 
severe in type 2 Stickler Syndrome, caused by mutations 
in COL11A1, than in type 1 Stickler syndrome. In the first 
description of the Stickler Syndrome associated with a 
COL11A1 mutation, Richards et al. [12], reported sensori-
neural hearing loss in 6 out of 7 individuals of a single fam-
ily. Poulson et al. [13] described 31 patients, from 6 pedi-
grees, with genetically confirmed type 2 Stickler Syndrome 
and the typical beaded vitreous phenotype. Of these, only 
45% reported hearing difficulties, but 80% of those tested 
had mild or moderate high-frequency sensorineural hearing 
loss demonstrated on audiometry, with only a small propor-
tion (10%) having superimposed conductive components 
(mixed hearing loss) [13].
Relatively few studies have described the auditory phe-
notype of the Stickler Syndromes in detail. Acke et al. [14] 
conducted a meta-analysis of the auditory phenotype of 
313 patients with Stickler Syndrome. Sixty-three percent 
of all patients were reported to have hearing loss, with the 
prevalence of hearing loss being 52% in type 1, compared to 
82.5% in type 2. In both groups, the majority of patients had 
sensorineural or mixed hearing loss, with only a minority 
(10.4% and 5.3% in type 1 and type 2, respectively) showing 
pure conductive loss.
Szymko-Bennett and colleagues assessed auditory dys-
function by means of audiometry and tympanometry in 
46 Stickler Syndrome patients from 26 family pedigrees 
[15]. When hearing loss was categorised into frequency 
and severity categories, the authors noted a greater sever-
ity in the high frequencies and in the older age group, with 
a prominence of mild-to-moderate impairment. However, 
when thresholds were adjusted for age-dependent normative 
data the dependence of the hearing loss on frequency was 
less obvious. 60% of individuals had at least two thresholds 
outside the 95th percentile of their age-matched reference 
data. Linear regression of hearing threshold at 4 kHz, 6 kHz 
and 8 kHz thresholds showed no significant progression of 
hearing loss beyond that expected of ageing (presbyacusis). 
Tympanometry assessed in 46 ears demonstrated that 21 
(46%) were hypermobile, a higher proportion than would 
be expected in a normal population. Genetic clarification 
was not sought in this study, although the authors presumed 
that “most, if not all” subjects had genetic abnormalities in 
COL2A1 (type 1 Stickler Syndrome).
Hearing assessment of only a limited number of individu-
als with type 2 Stickler Syndrome have been reported in the 
literature, which motivates the need to study and report a 
larger population. Furthermore, there is a lack of information 
guiding how classifications of severity and aetiology should 
be made, and much variation in reporting, where this infor-
mation is available in the Stickler Syndromes. Consequently, 
to establish the relative contribution of type 2 Stickler Syn-
drome on hearing impairment, in the context of the expected 
role of ageing of the auditory system (presbyacusis), careful 
comparison of findings with age- and gender-matched nor-
mative data is required.
The aim of the present study was to examine the audi-
tory phenotype of individuals with genetically confirmed 
type 2 Stickler Syndrome. We aimed to compare the relative 
proportions of conductive/mixed and sensorineural losses, 
and re-examine reports that hearing loss in type 2 Stickler 
Syndrome is restricted to high frequencies by comparing 
hearing thresholds with age- and gender-matched normative 
data. Tympanometry was used to determine the proportion 
of individuals with hypermobile tympanic membranes to 
facilitate comparison with previous studies. To ascertain 
if tympanic membrane hypermobility is acquired through 
repeated infection-related trauma, a clinical questionnaire 
regarding previous history of ear infections and otological 
symptoms was collected. In addition, results of a clinically 
validated hearing loss questionnaire, are reported and com-
pared to data from a population with similar audiometric 
profiles due to ‘typical’ aetiologies that contribute to hear-
ing loss. If hearing difficulties reported were significantly 
greater in the Stickler population than the comparative popu-
lation, this would suggest a potential role of central auditory 
processing alongside peripheral auditory impairment.
This is the largest cohort of genetically confirmed type 
2 Stickler Syndrome patients in the literature, and the only 
report detailing the auditory phenotype in this sub-group of 
the disorder.
Methods
Subjects with genetically confirmed type 2 Stickler Syn-
drome were recruited via the Nationally Commissioned 
Highly Specialised Stickler Syndrome diagnostic service 
held at Cambridge University Hospitals, UK (CUH). Data 
collected on each patient included demographics, otological 
history, pure-tone audiometry (PTA), tympanometry, and 
clinically validated auditory handicap questionnaires. This 
project was conducted following National Research Ethics 
Service approval (10/H0301/57).
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Otological history
Past otological history was assessed using a bespoke 
patient questionnaire (see appendix 2.1). The questionnaire 
documented subjective accounts of ear-related pathology, 
including self-reported hearing loss, frequency of ear 
infections, history of otological surgery and potential oto-
logical symptoms associated with auditory dysfunction.
Pure‑tone audiometry
Pure-tone audiometry was undertaken in a sound proofed 
booth following the Recommended Procedure of the Brit-
ish Society of Audiology [16] utilising a calibrated Mad-
sen Astera audiometer. Hearing impairment was defined 
as a pure-tone four-frequency average (4-FA) > 20 deci-
bels Hearing Level (dBHL) in at least one ear. The 4-FA 
was calculated as the average of pure-tone thresholds at 
500, 1000, 2000 and 4000 Hz. This definition of hear-
ing impairment is relatively conservative, but is selected 
to best represent a hearing impairment associated with 
significant impact on the individual’s quality of life. Hear-
ing impairment severity is calculated from the better ear 
four-frequency average. The degree of hearing loss was 
defined using British Society of Audiology (BSA) criteria 
for PTA (mild hearing loss 20–40 dBHL; moderate hear-
ing loss 41–70 dBHL; severe hearing loss 71–95 dB HL; 
profound hearing > 95 dB HL) [17]. Conductive hearing 
loss was defined as an air–bone gap > 20dBHL at two or 
more test frequencies between 1 and 4 kHz. The diagnosis 
of mixed hearing loss was made if the audiograms met the 
conductive hearing loss criteria, but with a bone conduc-
tion (BC) threshold > 20 dBHL at 500 Hz, 1 kHz, 2 kHz 
or 4 kHz. Data from sound field audiometry, and any tests, 
where pure-tone thresholds at 500 Hz, 1 kHz, 2 kHz and 
4 kHz were not present, in addition to any test in which BC 
thresholds had not been sufficiently masked, were excluded 
from analysis.
Tympanometry
Objective tympanometry (probe tone 226 Hz) assessed mid-
dle ear function by evaluating the impedance of sound by 
the tympanic membrane and middle ear structures [18]. A 
calibrated GSI Tympstar device was utilised. Tympanometry 
was performed and results assessed according to BSA guide-
lines [19], in addition to the Jerger classification method 
[20] (see Table 2). Tympanograms with a peak middle ear 
admittance  > 1.6 cm3 were considered as hypermobile and 
labelled as  Ad[18], and normal tympanograms were labelled 
as type A [18].
Auditory handicap questionnaire
Self-reported auditory handicap was assessed using the 
Speech, Spatial and Qualities of Hearing Scale (SSQ) ques-
tionnaire [21]. This clinically validated questionnaire con-
tains three sections, each relating to a particular aspect of 
hearing: speech comprehension, spatial hearing (the abil-
ity to locate, judge distance and direction of sounds in the 
environment), and the clarity and naturalness of sounds. It 
is particularly sensitive to assessing unilateral hearing loss. 
Each question was scored by the patient on a continuous 
scale from 0 to 10 (or non-applicable).
Statistical methods
Audiograms were independently assessed by two audiolo-
gists to classify aetiology in each ear. In addition to classi-
fication of severity, audiometric thresholds were compared 
to an age- and gender-matched normal-hearing population. 
Only subjects classified as having a purely sensorineural 
hearing loss were included for this analysis. The propor-
tion of individuals outside the  95th percentile for age- and 
gender-matched normative data (ISO 7029:2000(E)) was 
determined at each test frequency for those aged > 18 years. 
A χ2 analysis was used to determine if the proportion of 
individuals falling outside the 95th percentile was signifi-
cant. Cochran’s q test was used to investigate the effect of 
audiometric test frequency on the proportion of individuals 
falling outside the normal range.
Tympanometry data was assessed with regard to data 
reported in individual otological symptom questionnaires. A 
McNemar analysis was performed to determine if there was 
a significant difference in aetiology between the individuals 
presenting with  Ad tympanogram and those with type A.
Average total SSQ scores from our type 2 Stickler sample 
were compared to a population with a similarly matched 
level of hearing impairment used by Gatehouse and Noble 
[21] when validating the SSQ. An independent samples t 
test was used to compare the means of the two groups to 
determine if the type 2 Stickler population reported greater 
hearing difficulty compared to a population of individuals 
with similar audiometric thresholds arising from other, more 
typical, causes. P values < 0.05 were regarded as statistically 
significant.
Results
Eighty-three patients with genetically confirmed type 2 
Stickler Syndrome were recruited for study; 65 subjects were 
included in the analysis after 18 individuals were excluded 
due to incomplete audiograms. The mean age was 29.02 
(range 3–70, SD 19.24). Of the patient group 63.1% were 
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female (n = 41 mean age 27.12 years, range 3–64, SD 19.23), 
and 36.9% male (n = 24, mean age 32.25 years, range 5–70, 
SD 19.23).
Hearing loss severity
Using the definition of a hearing loss as a four-frequency 
average (4FA) worse than 20 dB HL, 69% of individuals 
[45/65] had a hearing loss in at least one ear. A mild hear-
ing loss in the better ear was the most common presentation, 
affecting 46% [30/65] of the population. The majority of 
hearing loss was bilateral and symmetrical. The proportion 
of individuals with different configurations of hearing loss 
is shown in more detail in Table 1.
Hearing impairment aetiology
The aetiology of hearing loss was assessed by PTA on an 
ear-by-ear basis. A total of 102 ears of 65 patients were 
included, following exclusion of ears, where underlying aeti-
ology could not be reliably established. The distribution of 
aetiologies, categorised according to age is shown in Fig. 1, 
and compared to previous meta-analysis data [14]. It can 
be seen that sensorineural hearing loss is the most common 
type of hearing loss seen in all age groups, affecting 77% of 
the total number of ears for which audiometric information 
was obtained. Smaller proportions of individuals presented 
with conductive (3%) and mixed (7%) hearing losses. Same-
day tympanometric information existed for four ears, where 
a conductive hearing loss had been identified. A type B tym-
panogram was observed in one case, suggesting a temporary 
conductive component associated with middle ear effusion) 
and type A tympanograms were present in the other cases, 
suggesting a permanent conductive hearing loss.
Averaged hearing thresholds, presented as an audiogram 
for three different age groups of patients with type 2 Stickler 
Syndrome, are shown in Fig. 2.
Table 1  Laterality and severity 
of hearing impairment (pure-
tone audiometry 4-frequency 
average worse than 20 dBHL in 
an ear), categorised according 
to age
Severity is based on British Society of Audiology descriptors applied to the better hearing ear [17]. 
*Asymmetry is calculated according to the criteria of > 15 dBHL difference between air-conduction thresh-
olds
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Fig. 1  Aetiology of hearing loss in type 2 Stickler Syndrome assessed 
on PTA and categorised by age. The final column shows meta-anal-
ysis aetiology of hearing loss data in both type 1 and 2 Stickler Syn-
drome published in Acke et al. [16]
Fig. 2  Audiogram of averaged hearing thresholds for three different 
age groups of patients with type 2 Stickler Syndrome
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Comparison with age‑matched normative data
The proportion of ears with sensorineural hearing loss 
identified to have thresholds falling outside the 95th per-
centile for each test frequency using age-specific audio-
metric data, along with corresponding χ2 and p values, is 
shown in Table 2. It can be seen that a large proportion 
of the type 2 Stickler cohort have audiometric test thresh-
olds significantly raised compared to those of age-matched 
normative data. Statistical tests (Chi-squared) were per-
formed to assess whether there was a relationship between 
raised hearing thresholds and test frequency. A significant 
influence of audiometric test frequency on the proportion 
of values that fall outside the 95th percentile is apparent 
(χ2 = 54.16, p < 0.01). McNemar’s pairwise comparisons 
(with Bonferroni corrections for multiple comparisons) 
indicated a complex relationship between frequency pairs 
and is not consistent with an obvious monotonic trend for 
greater hearing loss at higher audiometric frequency.
Tympanometry
Tympanometry results were assessed on an individual ear 
basis. Results were available for 90 ears. Forty-two (47%) 
tympanic membranes demonstrated normal type A tym-
panograms, 10 (11%) were classified as type B, 12 (13%) 
had negative middle ear pressure (type C) and 4 (5%) had 
perforations; 22 (24%) of examined tympanic membranes 
were hypercompliant (type  Ad).
Tympanometry categories correlated to the different 
aetiologies of hearing loss for 39 ears (measurements for 
both made on the same day) are shown in Fig. 3. No asso-
ciation with conductive hearing loss is apparent in any of 
the 15 ears with a Type  Ad hypercompliant tympanogram.
To assess whether hypercompliant tympanograms were 
linked to a history of recurrent ear infections, tympano-
gram outcomes were correlated to the reported otological 
history of previous ear infection. Only one of the eight 
patients with a type  Ad hypercompliant tympanogram who 
completed the questionnaire reported regular ear infec-
tions; of the 18 patients without hypercompliant tympa-
nograms who completed the questionnaire, five patients 
reported regular ear infections, suggesting ear infections 
were more common in patients that did not have type  Ad 
tympanograms.
Otological symptoms questionnaire
Forty-five patients completed the otological symptoms 
questionnaire. Thirty-four (77%) reported some degree of 
hearing impairment and eight (18%) reported recurrent ear 
infections, with a mean of three infections a year.
Speech spatial qualities questionnaire
Table 3 shows mean values for the three categories covered 
by the Speech, Spatial and Qualities of Hearing Scale ques-
tionnaire (Noble and Gatehouse, [21]). The total SSQ score 
obtained is significantly lower (greater difficulty) than a 
young, normal-hearing group (unpaired t test: t = 9.25), but 
there was no significant difference between the Stickler cohort 
and a group of individuals with mild–moderate bilateral sen-
sorineural hearing loss (unpaired t test: t = 0.279, df = 143, 
p = 0.7805). The results from the Stickler type 2 population 
Table 2  Proportion of 
individuals falling outside the 
95th percentile compared to age 
normative data for pure-tone 
audiometry
Test frequency 250 Hz 500 Hz 1 kHz 2 kHz 3 kHz 4 kHz 6 kHz 8 kHz
% of patients outside 
95th percentile
78 76 78 63 51 59 81 78
p value (chi-squared)  < 0.01  < 0.01  < 0.01  < 0.01  < 0.01  < 0.01  < 0.01  < 0.01
Fig. 3  Aetiology of hearing loss according to tympanometry classi-
fication
Table 3  SSQ questionnaire results for the three questionnaire 
domains from three separate cohorts
Stickler type 2, a symmetrical bilateral mild sensorineural hearing 
population [21] and a young normal-hearing population [22]




Speech 6.1 (2.3) 4.4 (2.4) 8.7 (0.9)
Spatial 6.5 (2.3) 5.6 (2.6) 8.5 (1.2)
Qualities 6.9 (2.0) 6.8 (2.7) 9.3 (0.6)
Total 6.5 (2.2) 5.6 (2.6) 8.8 (0.8)
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show that individuals tend to report similar difficulty when 
discriminating speech, in identifying the properties of sound 
perception linked to spatial perception, and the quality of 
sound perception. This is similar to the findings of Demeester 
et a.l, [22] who tested a young normal-hearing population. 
The population tested by Gatehouse et al. showed greater 
difficulty discriminating speech than the other two domains 
covered by the SSQ, and this may be partially explained by the 
fact that the population was on average older than the Stickler 
cohort (70 years (SD 8.3) vs. 37 years (SD 17), respectively).
Discussion
Hearing loss in previous Stickler Syndrome studies has been 
reported to be 80% in type 2 patients [14] and 60% in type 1 
patients [16]. However, direct comparison of reported out-
comes is difficult due to small cohorts and lack of a clear 
definition of hearing loss.
In the largest global cohort of genetically confirmed type 2 
Stickler Syndrome patients, with explicitly stated hearing loss 
definitions, we find hearing loss to be common. If audiomet-
ric thresholds are averaged across frequencies (four-frequency 
average) 69% [45/65] of individuals had hearing loss in at least 
one ear, and the majority of hearing loss was symmetrical. In 
patients with hearing loss, typically the severity was mild (75% 
of patients with loss), bilateral (87% of patients with a loss) 
and sensorineural (77% of ears). The selection of the 4-FA as 
the metric for hearing impairment was chosen, because it most 
accurately reflects a hearing loss likely to impair an individu-
al’s ability to follow a conversation. It is relatively conservative 
as an identifier of hearing loss—for example using a model for 
age-related sensorineural hearing loss, zero individuals would 
be expected to have 4-FA greater than 20 dB HL in a popula-
tion of healthy individuals with only age-related hearing loss 
of the same size as the cohort examined here. Thus it can be 
concluded that just over two-thirds of the population tested 
had hearing loss that can likely be attributed to type 2 Stickler 
Syndrome. If the least conservative metric for hearing loss is 
used (any one pure-tone frequency in excess of 20 dB HL), the 
proportion of individuals with a hearing loss rises to 94%, but 
this is likely to include individuals with hearing loss attribut-
able to ageing. Furthermore, in keeping with previous stud-
ies, audiograms generally displayed a greater impairment in 
the higher frequency regions [7, 13]. However, when age- and 
gender-matched normative data are accounted for, hearing loss 
is present across all test frequencies. This is consistent with 
widespread cochlear pathology, and this information may be 
important in future studies to investigate the underlying causes 
of sensorineural hearing loss in this condition.
Comparison of self-report disability scores obtained from 
this population and a young normal-hearing group showed the 
expected increase in reported difficulty, applying to speech 
discrimination, as well as spatial and sound quality perception 
[21]. When compared to a non-stickler population with simi-
lar average hearing thresholds [11], self-reported handicap 
scores were not statistically different, inferring that the levels 
of hearing disability are consistent with pure-tone audiometric 
thresholds. This would also suggest hearing difficulties are 
not exacerbated by a significant retrocochlear or processing 
abnormality, but the observed sensorineural hearing loss is 
most consistent with impairment in the auditory periphery.
The exact pathophysiology of Stickler Syndrome type 2 
associated hearing impairment remains unknown. Tempo-
ral bone computed tomography (CT) scans have revealed no 
macro-deformity of the inner ear [15]. The underlying collagen 
defect may, therefore, cause hearing loss due to microstructure 
irregularity. The COL11A1 and COL11A2 proteins have been 
reported in the developing mouse cochlear [11] and in a mouse 
model, COL11A1 haploinsufficiency does not cause signifi-
cant hearing loss [23], whereas in humans haploinsufficiency 
has been reported to cause mild hearing loss [24]. In the major-
ity of type 2 Stickler Syndrome cases, the pathogenic variant 
is a missense change or an in-frame deletion [1, 4, 8, 25, 26] 
and the abnormal COL11A1 pro-alpha chain exerts a dominant 
negative effect on normal type XI collagen expression in the 
cochlear extracellular matrix [15]. In rare cases of recessive 
type 2 Stickler Syndrome due to bi-allelic null or missense/null 
mutations, no normal pro-alpha 1(XI), is synthesised, resulting 
in profound hearing loss [27, 28].
24% of patients were found to have hypermobile tym-
panic membranes; this is lower than the incidence of 36–46% 
reported in type 1 Stickler Syndrome patients [15, 29]. Otol-
ogy questionnaire responses suggested that tympanic mem-
brane hypermobility was not acquired through infection-
related trauma. It is hypothesised that mutated COL11A1 
fibrils are likely to be present in the fibrous layer of the 
tympanic membrane, where other collagen types have been 
demonstrated to be present [30]. This motivates further inves-
tigation of primary collagen defects present in the tympanic 
membranes of patients with type 2 Stickler Syndrome and 
further investigation into the correlation between joint hyper-
mobility and hypercompliant tympanic membranes [15].
A reticence to test below 20 dBHL for a clinical assess-
ment may have potentially introduced testing bias, with the 
potential for over emphasising differences between the study 
population and age-matched normative data for mid- and 
low-frequencies thresholds. However, the existing data sug-
gest the severity of hearing loss in those patients found to 
have mid- and low-frequency thresholds outside the normal 
range would not have been affected by this ‘floor’ effect. 
Thus, low frequency hearing loss reported in the current 
type 2 Stickler Syndrome population is unlikely to be an 
artefact, and confirms with previously reported studies [14].
The tympanometry protocol performed in this study 
utilised probe tones at 226  Hz. Whilst useful clinical 
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information was gleaned, recently developed wideband 
acoustic immittance techniques describe middle ear func-
tion across a wide frequency range, and normative data is 
now available [31]. Future application of such techniques to 
individuals with the Stickler Syndromes may yield detailed 
data about middle ear function.
Conclusion
This is the largest study investigating audiological phenotype 
of genetically confirmed type 2 Stickler individuals. The 
dataset comprises pure-tone audiometry and tympanometry, 
as well as self-reported handicap and otological pathology 
information. The study is also the first to consider age–gen-
der matched normative data with regards to hearing impair-
ment in the type 2 Stickler Syndrome. Details are included 
of how hearing loss aetiology and severity are classified, 
which is often lacking in previous studies, in addition to 
strict criteria when defining hearing loss. A high prevalence 
of cochlear hearing loss, with evidence of dysfunction across 
the audible frequency range, rather than restricted to the 
high-frequencies, was demonstrated. Hypermobile tympa-
nograms are likely to be due to intrinsic tympanic membrane 
defects, rather than associated with previous perforations 
due to otitis media, but are less common than in type 1 Stick-
ler Syndrome.
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Appendix 1: Otological symptoms 
questionnaire
Do you feel you have a hearing problem?
Is this in one or both ears?
Does your hearing fluctuate (come and go)?
Do you suffer from regular ear infections?
If so is this just in one ear?
Approximately how many ear infections do you get per 
year?
Do you get and fluid/infection/pus coming out of your 
ears?
Have you ever had any operations on your ears (including 
grommets)?
Do you ever get any ringing or buzzing sounds in your 
ears that last longer than a few minutes?
Do you ever suffer from a sensation of dizziness that feels 
like spinning or rotating sensation?
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